MABTAS RA 500, containing Rituximab, is primarily used in the treatment of certain cancers, including non-Hodgkin lymphoma and chronic lymphocytic leukemia. It also plays a role in managing autoimmune diseases such as rheumatoid arthritis and granulomatosis with polyangiitis.